Vanna Maria Valori

Casa Sollievo della Sofferenza — Italy

Biochemistry, Genetics and Molecular Biology · Life Sciences

18h-index1.2kcitations81works2.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Epigenetics and DNA Methylation(19), MicroRNA in disease regulation(18), Cancer-related molecular mechanisms research(15), Cancer-related gene regulation(13), RNA modifications and cancer(7)

Publications80 total

Development of a microRNA-based prognostic model for accurate prediction of distant metastasis in breast cancer patients
Breast Cancer Research·2025· 1 citedOpen Access
Abstract P3-07-22: A miRNA expression profiling of breast cancer to develop a metastases predictor model and identify new molecular players of metastatic outgrowth
Clinical Cancer Research·2025
Tumor Suppressor miR-27a-5p and Its Significance for Breast Cancer
Biomedicines·2024· 5 citedOpen Access
Supplementary figures 1-4 from Changes in CpG Islands Promoter Methylation Patterns during Ductal Breast Carcinoma Progression
2023Open Access
Data from Changes in CpG Islands Promoter Methylation Patterns during Ductal Breast Carcinoma Progression
2023Open Access
Supplementary Tables 1-4 from Changes in CpG Islands Promoter Methylation Patterns during Ductal Breast Carcinoma Progression
2023Open Access
Supplementary figures 1-4 from Changes in CpG Islands Promoter Methylation Patterns during Ductal Breast Carcinoma Progression
2023Open Access
Supplementary Tables 1-4 from Changes in CpG Islands Promoter Methylation Patterns during Ductal Breast Carcinoma Progression
2023Open Access
Data from Changes in CpG Islands Promoter Methylation Patterns during Ductal Breast Carcinoma Progression
2023Open Access
Nonalcoholic Steatohepatitis: A 9-Year Follow Up Cohort Study
Journal of Clinical Medicine·2022Open Access
Combined analysis of miR-200 family and its significance for breast cancer
Scientific Reports·2021· 36 citedOpen Access
Abstract 1422: Clinical association of miR-155-5p with breast cancer and its relevance for treatment with PARP inhibitors
Cancer Research·2020
Hsa-miR-155-5p Up-Regulation in Breast Cancer and Its Relevance for Treatment With Poly[ADP-Ribose] Polymerase 1 (PARP-1) Inhibitors
Frontiers in Oncology·2020· 53 citedOpen Access
Hepatocellular carcinoma in adult thalassemia patients: an expert opinion based on current evidence
BMC Gastroenterology·2020· 20 citedOpen Access
Hsa-miR-210-3p expression in breast cancer and its putative association with worse outcome in patients treated with Docetaxel
Scientific Reports·2019· 41 citedOpen Access
Oral anticancer therapy project: Clinical utility of a specific home care nursing programme on behalf of Italian Association of Medical Oncology (AIOM)
Journal of Clinical Nursing·2019· 4 cited
Abstract 4904: High levels of microRNA-210-3p are associated with increased risk of disease progression in breast cancer patients treated with docetaxel
Clinical Research (Excluding Clinical Trials)·2019
Abstract 5394: Initial results from TRANSCAN ERA-NET BREMIR project: MicroRNAs expression profiling for identification of breast cancer patients at high risk to develop distant metastases
Cancer Research·2018
Abstract 4734: miR-9-5p expression in breast cancer correlates with hormone receptor status and affects patients survival
Cancer Research·2017· 1 cited
Stepwise analysis of MIR9 loci identifies miR-9-5p to be involved in Oestrogen regulated pathways in breast cancer patients
Scientific Reports·2017· 51 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Paola Parrella(31), Vito Michele Fazio(29), Evaristo Maiello(28), Raffaela Barbano(25), Massimiliano Copetti(23), Roberto Murgo(17), Barbara Pasculli(16), Massimo Carella(12), Andrea Fontana(11), Michelina Coco(11), Paolo Graziano(11), Michelina Rendina(11), Maria Morritti(11), Lucia Anna Muscarella(8), Teresa Balsamo(8), Michele Bisceglia(8), Maria Luana Poeta(8), Manel Esteller(8), Annamaria la Torre(7), Antonietta Pia Gallo(7)